Masandang, Rosalina G.

HRN: 26-68-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2025
MUPIROCIN 2%, 15G (TUBE)
02/13/2025
02/20/2025
IV
600mg
Q6
Herpes Zoster
Rejected 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Guideline Not Available